Epidermal Growth Factor Receptor-Targeted Therapy for Pancreatic Cancer

ISSN： 0735-7907

Source： Cancer Investigation, Vol.25, Iss.7, 2007-10, pp. : 647-657

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can we predict the response to epidermal growth factor receptor targeted therapy?

By Manegold Philipp

Targeted Oncology, Vol. 3, Iss. 2, 2008-04 ,pp. : 87-99

Springer Publishing Company

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Antagonists in Pancreatic Cancer: What is Their Role?

By Tang Patricia A. Moore Malcolm J.

American Journal of Cancer, Vol. 5, Iss. 4, 2006-01 ,pp. : 213-221

Adis International

Access to resources Recommend Favorite

Serum and Correspondent Tissue Measurements of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGF-R): Clinical Relevance in Pancreatic Cancer and Chronic Pancreatitis

International Journal of Gastrointestinal Cancer, Vol. 25, Iss. 2, 1999-04 ,pp. : 89-96

Humana Press, Inc

Access to resources Recommend Favorite

TRAIL receptor-targeted therapy

By Buchsbaum Donald J Zhou Tong LoBuglio Albert F

Future Oncology, Vol. 2, Iss. 4, 2006-08 ,pp. : 493-508

Future Medicine

Access to resources Recommend Favorite

Epidermal growth factor receptor inhibitors in cancer treatment

By Ciardiello Fortunato

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 221-234

Future Medicine

Access to resources Recommend Favorite